Zobrazeno 1 - 10
of 311
pro vyhledávání: '"M Wagenaar"'
Autor:
Xueyu Chen, Dongshan Han, Xuan Wang, Xuemei Huang, Zilu Huang, Yijun Liu, Junyan Zhong, Frans J. Walther, Chuanzhong Yang, Gerry T. M. Wagenaar
Publikováno v:
Respiratory Research, Vol 24, Iss 1, Pp 1-13 (2023)
Abstract Background Ibuprofen is a nonsteroidal anti-inflammatory drug that is commonly used to stimulate closure of a patent ductus arteriosus (PDA) in very premature infants and may lead to aberrant neonatal lung development and bronchopulmonary dy
Externí odkaz:
https://doaj.org/article/11f3eded1e27400186e965236fe8a969
Autor:
Zilu Huang, Bingchun Lin, Dongshan Han, Xuan Wang, Junyan Zhong, Gerry T. M. Wagenaar, Chuanzhong Yang, Xueyu Chen
Publikováno v:
Frontiers in Pediatrics, Vol 10 (2022)
Previous studies suggest that platelets are involved in fetal and adult lung development, but their role in postnatal lung development especially after premature birth is elusive. There is an urgent need to scrutinize this topic because the incidence
Externí odkaz:
https://doaj.org/article/f84adf8423eb432288b17998c784da6f
Autor:
Femke F. Schröder, Corine E. Post, Sjoerd M. van Raak, Frank F. J. Simonis, Frank-Christiaan B. M. Wagenaar, Rianne M. H. A. Huis in’t Veld, Nico Verdonschot
Publikováno v:
Journal of Experimental Orthopaedics, Vol 7, Iss 1, Pp 1-10 (2020)
Abstract Purpose Low-field MRI, allowing imaging in supine and weight-bearing position, may be utilized as a non-invasive and affordable tool to differentiate between causes of dissatisfaction after TKA (‘problematic TKA’). However, it remains un
Externí odkaz:
https://doaj.org/article/baaf74743e284a3e9548e5b6b0d558a8
Autor:
Xueyu Chen, Junyan Zhong, Dongshan Han, Fang Yao, Jie Zhao, Gerry. T. M. Wagenaar, Chuanzhong Yang, Frans J. Walther
Publikováno v:
Frontiers in Pediatrics, Vol 9 (2021)
Bronchopulmonary dysplasia (BPD) is a neonatal chronic lung disease characterized by an arrest in alveolar and vascular development. BPD is secondary to lung immaturity, ventilator-induced lung injury, and exposure to hyperoxia in extremely premature
Externí odkaz:
https://doaj.org/article/c026c973338e4d86807f76dfcd381bae
Autor:
Hendrik J. F. Helmerhorst, Laura R. A. Schouten, Gerry T. M. Wagenaar, Nicole P. Juffermans, Joris J. T. H. Roelofs, Marcus J. Schultz, Evert de Jonge, David J. van Westerloo
Publikováno v:
Intensive Care Medicine Experimental, Vol 5, Iss 1, Pp 1-14 (2017)
Abstract Background Mechanical ventilation and hyperoxia have the potential to independently promote lung injury and inflammation. Our purpose was to study both time- and dose-dependent effects of supplemental oxygen in an experimental model of mecha
Externí odkaz:
https://doaj.org/article/6510ee9d9e3048d99ea3d39b25a1b427
Publikováno v:
South African Journal of Science, Vol 115, Iss 3/4 (2019)
Aquatic environments around the world have become mixtures of different types of pollutants, including pharmaceuticals. The presence of pharmaceuticals in aquatic environments has raised concerns regarding the possibility of unintended effects on aqu
Externí odkaz:
https://doaj.org/article/bd12c63e416f4f1d8f0aaa05e346f5b8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Xueyu Chen, Mar Orriols, Frans J. Walther, El Houari Laghmani, Annemarie M. Hoogeboom, Anne C. B. Hogen-Esch, Pieter S. Hiemstra, Gert Folkerts, Marie-José T. H. Goumans, Peter ten Dijke, Nicholas W. Morrell, Gerry T. M. Wagenaar
Publikováno v:
Frontiers in Physiology, Vol 8 (2017)
Aim: Effective treatment of premature infants with bronchopulmonary dysplasia (BPD) is lacking. We hypothesize that bone morphogenetic protein 9 (BMP9), a ligand of the TGF-β family that binds to the activin receptor-like kinase 1 (ALK1)-BMP recepto
Externí odkaz:
https://doaj.org/article/5a74e575439a4195ac860449f9e50a0b
Publikováno v:
08.01 - Thoracic surgery.
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 166
Patients with intermediate-high risk pulmonary embolism have a different mix of clinical symptoms. Optimal treatment of patients with intermediate high-risk pulmonary embolism is necessary to prevent short-term mortality. According to the current gui